Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

28.0300 USD 0.7700 2.67%

As of 20:04:07 ET on 01/30/2015.

Company Profile for Emergent Biosolutions Inc (EBS)

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Contact Information

Emergent Biosolutions Inc

2273 Research Boulevard
Suite 400
Rockville, MD 20850
United States
Phone: 1-301-795-1800
Fax: 1-301-795-1899

Key Executives for Emergent Biosolutions Inc (EBS)

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
Anatolio B Cruz IIIExec VP/Gen Cnsl/SecretaryRobert G Kramer SrExec VP:Corporate Services/CFO
Scott C StromattSenior VP/Chief Medical OfficerRobert G Burrows "Bob"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil